Shihui Lv
Overview
Explore the profile of Shihui Lv including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lv S, Guo Q, He Y, Yu Z, Zhan X, Li H, et al.
Front Immunol
. 2024 Sep;
15:1459967.
PMID: 39267764
Introduction: Kidney cancer (KC) is a significant health burden globally, with over 400,000 new cases estimated in 2020. The prognosis of KC is influenced by various factors, including tumor spread,...
2.
Lv S, Tao L, Liao H, Huang Z, Lu Y
Funct Integr Genomics
. 2023 Jun;
23(2):193.
PMID: 37264263
Substantial progress has been made in cancer biology and treatment in recent years, but the clinical outcome of patients with renal cell carcinoma (RCC) remains unsatisfactory. The tumor microenvironment (TME)...
3.
Jiang W, Quan R, Bhandari A, Hirachan S, Chen C, Lv S, et al.
Curr Med Chem
. 2023 Apr;
31(9):1152-1164.
PMID: 37102492
Introduction: Thyroid carcinoma (TC) is currently the prevalent type of endocrine malignancy worldwide, having an incidence of around 15.5 per 100,000 people. However, the underlying mechanisms of TC tumorigenesis remain...
4.
Chen J, Bhandari A, Hirachan S, Lv S, Mainali S, Zheng C, et al.
Endocr Metab Immune Disord Drug Targets
. 2023 Apr;
24(7):789-797.
PMID: 37056066
Aims: Papillary thyroid cancer (PTC) is one of the subtypes of thyroid cancer with increasing incidence worldwide, but the molecular mechanism is still unclear. Background: Papillary thyroid cancer (PTC) is...
5.
Niu Z, Wang F, Lv S, Lv Y, Liu M, Fu L, et al.
Mol Cell Biol
. 2021 Jul;
41(10):e0011521.
PMID: 34309414
Long noncoding RNAs (lncRNAs) have key functions in modulating cervical cancer (CC) genesis and progression. This work focused on exploring lncRNA HNRNPU-AS1's function in CC and the underlying mechanism. HNRNPU-AS1,...
6.
Dong X, Lv S, Gu D, Zhang X, Ye Z
Front Oncol
. 2021 Feb;
10:553628.
PMID: 33552947
The role of L Antigen Family Member 3 (LAGE3) in breast cancer (BC) has not been sufficiently studied. In this study, we explored the clinical value and biological functions of...
7.
Dong X, Yang Q, Gu J, Lv S, Song D, Chen D, et al.
Int Immunopharmacol
. 2020 Dec;
90:107267.
PMID: 33310661
Background: Papillary thyroid cancer (PTC) is heterogeneous cancer with many different immune cells involved in its pathogenesis. L Antigen Family Member 3 (LAGE3) is an ESO/LAGE gene family member that...
8.
Dong X, Lv S, Zhang X, Li Q
Front Surg
. 2020 Nov;
7:586106.
PMID: 33251243
Metastatic subcutaneous implantation of the follicular variant of papillary thyroid cancer is very rare. We present a 62-year-old woman with a history of follicular variant of papillary thyroid cancer, who...
9.
Dong X, Lv S, Zhang X, Hao R
Int Immunopharmacol
. 2020 May;
85:106599.
PMID: 32438075
Background: Colorectal cancer (CRC) is the primary cause of cancer-related deaths worldwide. Identification of new CRC biomarkers is imperative to improve the prognosis and development of therapies against the disease....